Amedisys (AMED) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Cost of service, excluding depreciation and amortization: 212.12M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Cost of service, excluding depreciation and amortization: 212.12M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
